| 000 | 02003cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031420.0 | ||
| 008 | 160201s2015 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.01.Ph.D.2015.Ha.E | ||
| 100 | 0 | _aHanan Ibrahim Eltartoushy | |
| 245 | 1 | 0 |
_aEffect of intravenous glutamine supplementation in severely burn critically ill patient receiving enteral nutrition study protocol : _bA prospective, blinded, randomized, placebo controlled clinical trial / _cHanan Ibrahim Eltartoushy ; Supervised Abderahman Fathalla , Ahmed Helmy , Nashwa Nabil |
| 246 | 1 | 5 |
_aتأثير حقن مكملات الجلوتامين عن طريق الوريد فى مرضى العناية الحرجة الذين يعانون من حرق شديد و يتلقون تغذية معوية : _bتجربة سريرية مستقبلية عشوائية محكمة الغفل |
| 260 |
_aCairo : _bHanan Ibrahim Eltartoushy , _c2015 |
||
| 300 |
_a117 Leaves ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Anaesthesia | ||
| 520 | _aThis study was done to determine whether providing intravenous alanyl - glutamine (0.5 g / kg / day) will be associated with improved clinical outcomes in the term of reduced severity of organ dysfunction, length of stay in ICU, length of stay in hospital, number of days on mechanical ventilation, number of days of antibiotic use during ICU stay, in hospital mortality in compared with placebo in critically ill burn patients | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aInfection | |
| 653 | 4 | _aIntravenous glutamine | |
| 653 | 4 | _aSevere burn | |
| 700 | 0 |
_aAbdelrahman Fathalla , _eSupervisor |
|
| 700 | 0 |
_aAhmed Helmy , _eSupervisor |
|
| 700 | 0 |
_aNashwa Nabil , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c54847 _d54847 |
||